Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Liver Cancer 2017 NCI 5R01CA178063-04 Role of beta-catenin in apoptosis resistance of hepatocellular carcinoma RANA, BASABI UNIVERSITY OF ILLINOIS AT CHICAGO IL $331,793
Liver Cancer 2017 NCI 5R03CA191978-02 Optimization of radiofrequency ablation with electrically conductive particles KIM, CHARLES DUKE UNIVERSITY NC $79,500
Liver Cancer 2017 NIAAA 1R01AA024169-01A1 Molecular mechanism of alcohol-associated liver tumor development ZHONG, SHUPING UNIVERSITY OF SOUTHERN CALIFORNIA CA $371,250
Liver Cancer 2017 NCI 5R21CA190945-02 Novel Point-of-Care Tool to Predict Response to Sorafenib in Hepatocellular Carcinoma KASEB, AHMED UNIVERSITY OF TX MD ANDERSON CAN CTR TX $208,800
Liver Cancer 2017 NCI 5R01CA184456-02 VDAC Regulation of Warburg Metabolism in Hepatocarcinoma MALDONADO, EDUARDO MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $341,981
Liver Cancer 2017 NCI 5R03CA201988-02 Role of Nucleostemin in Conferring The Drug Resistance of Hepatocellular Carcinoma TSAI, ROBERT TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR TX $74,250
Liver Cancer 2017 NCI 5R01CA175380-04 FoxM1 in liver cancer. RAYCHAUDHURI, PRADIP UNIVERSITY OF ILLINOIS AT CHICAGO IL $405,146
Liver Cancer 2017 NCI 5R01CA181658-03 MRI-Monitored Delivery of Sorafenib-Eluting Microspheres to Liver Tumors LARSON, ANDREW NORTHWESTERN UNIVERSITY AT CHICAGO IL $449,254
Liver Cancer 2017 NIDDK 5R01DK056621-16 Hepatic autophagy, Stem cells and Fibrosis FRIEDMAN, SCOTT ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $381,375
Liver Cancer 2017 NCI 5R01CA190844-03 Hepatic Stellate Cells and Liver Cancer SCHWABE, ROBERT COLUMBIA UNIVERSITY HEALTH SCIENCES NY $356,751
Liver Cancer 2017 NIAAA 5P50AA011999-19 8467 Functional Dissection of EtOH-med Self-renew of Liver Tumor-Int Cells via TLR4 MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $206,355
Liver Cancer 2017 NCI 5R01CA172086-04 PROHIBITIN 1 IN LIVER INJURY AND CANCER LU, SHELLY CEDARS-SINAI MEDICAL CENTER CA $312,404
Liver Cancer 2017 NCATS 1R21TR001743-01 Targeting glucose metabolism for the treatment of Hepatocellular Carcinoma CHEN, BIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $292,022
Liver Cancer 2017 NCI 5R01CA102325-11 15-PGDH in Cholangiocarcinogenesis WU, TONG TULANE UNIVERSITY OF LOUISIANA LA $344,269
Liver Cancer 2017 NIA 5R01AG016927-19 The Role of Akt in Cell Survival and Cell Growth HAY, NISSIM UNIVERSITY OF ILLINOIS AT CHICAGO IL $455,327
Liver Cancer 2017 NCI 5R01CA190776-03 A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis EL-SERAG, HASHEM BAYLOR COLLEGE OF MEDICINE TX $636,729
Liver Cancer 2017 NCI 5R01CA193244-07 Role of microR-122 in Hepatocarcinogenesis using Conditional Knockout Mice GHOSHAL, KALPANA OHIO STATE UNIVERSITY OH $365,750
Liver Cancer 2017 NIDDK 5R01DK074932-11 LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease HUI, DAVID UNIVERSITY OF CINCINNATI OH $355,500
Liver Cancer 2017 NCI 1R01CA211794-01 Role of p62/SQSTM1 in obesity-induced liver cancer KARIN, MICHAEL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $739,996
Liver Cancer 2017 NIBIB 5R21EB022291-02 Transarterial Immunomodulatory Embolization: A novel approach to cancer therapy AMEER, GUILLERMO NORTHWESTERN UNIVERSITY IL $188,128
Liver Cancer 2017 NCI 1UG3CA211232-01 Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer CHILKOTI, ASHUTOSH DUKE UNIVERSITY NC $399,986
Liver Cancer 2017 NCI 5U01CA172320-05 Evaluation of HCC Response to Systemic Therapy with Quantitative MRI TAOULI, BACHIR ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $485,638
Liver Cancer 2017 NCI 1UG3CA211551-01 Field-deployable platform for prognostic hepatic cancer screening in low-resource settings PORTER, MARC UNIVERSITY OF UTAH UT $399,914
Liver Cancer 2017 NCI 5R01CA188305-03 Role of NCOA5 in hepatic steatosis and hepatocarcinogenesis XIAO, HUA MICHIGAN STATE UNIVERSITY MI $338,538
Liver Cancer 2017 NIDDK 5R01DK102667-03 Innovative Genetic Approaches for Hepatic Repopulation KAESTNER, KLAUS UNIVERSITY OF PENNSYLVANIA PA $360,000
Liver Cancer 2017 NCI 5R01CA185169-04 Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics MCKNIGHT, STEVEN UT SOUTHWESTERN MEDICAL CENTER TX $475,351
Liver Cancer 2017 NCI 5R01CA083650-15 Altered Growth Factor Pathways in Biliary Cancer SIRICA, ALPHONSE VIRGINIA COMMONWEALTH UNIVERSITY VA $307,269
Liver Cancer 2017 NCI 5R01CA168912-04 Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines HE, YUKAI AUGUSTA UNIVERSITY GA $320,588
Liver Cancer 2017 NIDDK 5R01DK090311-07 Estrogen Regulation of Hepatic Growth GOESSLING, WOLFRAM BRIGHAM AND WOMEN'S HOSPITAL MA $629,907
Liver Cancer 2017 NCI 5R01CA190144-03 Liver Cancer Risk with rAAV Gene Therapy GROMPE, MARKUS OREGON HEALTH & SCIENCE UNIVERSITY OR $585,925
Liver Cancer 2017 NIDDK 5R01DK054921-19 Cyclin D1/CDK4 Complex in Hepatocyte Proliferation ALBRECHT, JEFFREY UNIVERSITY OF MINNESOTA MN $351,689
Liver Cancer 2017 NCI 1R03CA212877-01 Tumor Molecular Profiling and Response to Immunotherapy in Advanced Biliary Cancers KELLEY, R. UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $79,250
Liver Cancer 2017 NCI 5R01CA086978-14 Molecular mechanism of diet-induced carcinogenesis JACOB, SAMSON OHIO STATE UNIVERSITY OH $311,850
Liver Cancer 2017 NCI 5R01CA176012-04 Molecular and cellular communications in liver tumorigenesis FENG, GEN-SHENG UNIVERSITY OF CALIFORNIA SAN DIEGO CA $321,625
Liver Cancer 2017 NCI 5R01CA200310-02 Functions of BNIP3 in lipid metabolism in the liver and in hepatocellular carcinoma MACLEOD, KAY UNIVERSITY OF CHICAGO IL $397,573
Liver Cancer 2017 NCI 1R01CA204446-01A1 Antivascular ultrasound therapy of primary liver neoplasia SEHGAL, CHANDRA UNIVERSITY OF PENNSYLVANIA PA $389,702
Liver Cancer 2017 NIDDK 5R01DK104956-03 Molecular Imaging of Liver Fibrosis FUCHS, BRYAN MASSACHUSETTS GENERAL HOSPITAL MA $532,832
Liver Cancer 2017 NCI 1R01CA204996-01A1 Determining Unique Metabolic features of Hepatocellular Carcinoma. LU, ZHIMIN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $366,000
Liver Cancer 2017 NCI 2R01CA139158-06A1 MiRNAs in hepatocellular carcinoma development and treatment HUANG, WENDONG BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $410,875
Liver Cancer 2017 NCI 5R21CA205501-02 Developing Therapy for the Treatment of Cholangiocarcinoma YOON, KARINA UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $159,863
Liver Cancer 2017 NCI 5R01CA154986-05 The role of PTEN and AKT2 in the malignant transformation of liver progenitor cel STILES, BANGYAN UNIVERSITY OF SOUTHERN CALIFORNIA CA $342,375
Liver Cancer 2017 NIDDK 1R13DK112338-01 Bile Acid Receptors as Signal Integrators in Liver and Metabolism JARVIS, THALE KEYSTONE SYMPOSIA CO $7,500
Liver Cancer 2017 NIDDK 5R01DK108743-02 Control of stellate cells-driven liver cancer by the p62/NBR1 adapters MOSCAT, JORGE SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $433,352
Liver Cancer 2017 NCI 5R01CA194574-03 Enhancing Liver Cancer Treatment With Image-Guided Magnetic Hyperthermia LIAPI, ELENI JOHNS HOPKINS UNIVERSITY MD $648,094
Liver Cancer 2017 NCI 5R01CA194307-02 2D and 3D Contrast-enhanced Ultrasound Evaluation of HCC Chemoembolization EISENBREY, JOHN THOMAS JEFFERSON UNIVERSITY PA $548,690
Liver Cancer 2017 NCI 5R01CA186566-03 Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC) HASSAN, MANAL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $655,272
Liver Cancer 2017 NIDDK 5R01DK100289-04 Signaling Pathways Influencing Liver Disease Phenotype in Antitrypsin Deficiency PERLMUTTER, DAVID WASHINGTON UNIVERSITY MO $452,417
Liver Cancer 2017 NCI 5R01CA080946-17 Selenoproteins as targets for cancer prevention GLADYSHEV, VADIM BRIGHAM AND WOMEN'S HOSPITAL MA $316,004
Liver Cancer 2017 NIGMS 5R01GM118122-17 Metabolism of Carcinogens and Drugs by Human P450s GUENGERICH, F VANDERBILT UNIVERSITY TN $368,951
Liver Cancer 2017 NCI 5R01CA204586-02 Yap and beta-catenin interactions in liver: Implications in Pathophysiology MONGA, SATDARSHAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $414,072
Liver Cancer 2017 NCI 5R01CA190606-02 Signaling cascades in cholangiocarcinoma development CHEN, XIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $362,569
Liver Cancer 2017 NCI 5R01CA190678-03 Mechanisms of obesity-induced hepatocarcinogenesis CHUNG, FUNG-LUNG GEORGETOWN UNIVERSITY DC $380,255
Liver Cancer 2017 NCI 5R01CA200597-02 HMGB1 as Link Between Hepatocellular Injury and HCC SCHWABE, ROBERT COLUMBIA UNIVERSITY HEALTH SCIENCES NY $443,761
Liver Cancer 2017 NIBIB 5R21EB022298-02 3D Passive Cavitation Imaging-Guided Therapeutic Delivery of MicroRNA into Cancer WILLMANN, JUERGEN STANFORD UNIVERSITY CA $245,069
Liver Cancer 2017 NCI 1R13CA213778-01 2017 Cholangiocarcinoma Foundation Annual Conference LINDSEY, STACIE CHOLANGIOCARCINOMA FOUNDATION UT $5,000
Liver Cancer 2017 NCI 1U01CA202934-01A1 Optical and electromagnetic tracking guidance for hepatic interventions MAHMOOD, UMAR MASSACHUSETTS GENERAL HOSPITAL MA $421,989
Liver Cancer 2017 NIEHS 2P42ES010337-16 5193 Project 1: Control of Toxin Obesity Induced Liver Fibrosis by B Cells KARIN, MICHAEL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $299,658
Liver Cancer 2017 NIEHS 2P42ES010337-16 5195 Project 3: Molecular and Microbial Mechanisms Leading to Triclosan Induced Liver Fibrosis TUKEY, ROBERT UNIVERSITY OF CALIFORNIA SAN DIEGO CA $299,660
Liver Cancer 2017 NCI 5R01CA112192-10 Real-time Ultrasonic Monitoring of Tumor Ablation VARGHESE, TOMY UNIVERSITY OF WISCONSIN-MADISON WI $146,852
Liver Cancer 2017 NCI 5U54CA193417-03 7363 Liver Cancer: pre-Malignant Stiffening, Membrane Transduction, & Nuclear Rheology: Administrative Core DISCHER, DENNIS UNIVERSITY OF PENNSYLVANIA PA $380,699
Liver Cancer 2017 NCI 5U54CA193417-03 7364 Core 1: Cell and Tissue Core WELLS, REBECCA UNIVERSITY OF PENNSYLVANIA PA $276,357
Liver Cancer 2017 NCI 5U54CA193417-03 7365 Core 2: Theory Core - Multiscale models for mechano-chemical phenomena LIU, ANDREA UNIVERSITY OF PENNSYLVANIA PA $276,356
Liver Cancer 2017 NCI 5U54CA193417-03 7366 Project 1: Mechanisms of Stiffening in Liver Cancer DISCHER, DENNIS UNIVERSITY OF PENNSYLVANIA PA $346,854
Liver Cancer 2017 NCI 5U54CA193417-03 7367 Project 2: Physical Mechanisms and Clinical Implications of Mechano-transduction RADHAKRISHNAN, RAVI UNIVERSITY OF PENNSYLVANIA PA $321,413
Liver Cancer 2017 NCI 5U54CA193417-03 7368 Project 3: Nuclear Rheology & Stability in Cancer DISCHER, DENNIS UNIVERSITY OF PENNSYLVANIA PA $334,133
Liver Cancer 2017 NCI 5U54CA193417-03 7369 PSOC@Penn Education and Outreach DISCHER, DENNIS UNIVERSITY OF PENNSYLVANIA PA $140,993
Liver Cancer 2017 NCI 5R01CA181566-03 Compact Representations of Dynamic Liver MRI SPINCEMAILLE, PASCAL WEILL MEDICAL COLL OF CORNELL UNIV NY $387,731
Liver Cancer 2017 NCI 5R01CA190525-03 Reactivation of embryonic growth programs in liver cancer ZHU, HAO UT SOUTHWESTERN MEDICAL CENTER TX $370,575
Liver Cancer 2017 NIBIB 5R01EB016960-05 Pressure-Driven Local Drug Delivery System for Treatment of Liver Cancer EXNER, AGATA CASE WESTERN RESERVE UNIVERSITY OH $356,625
Liver Cancer 2017 NIBIB 5R01EB022148-02 Cancer-specific nanoparticle-mediated gene therapy to treat hepatocellular carcinoma GREEN, JORDAN JOHNS HOPKINS UNIVERSITY MD $364,500
Liver Cancer 2017 NIDDK 5F31DK107254-02 SRC-2 and AMPKa2 in liver metabolism and Non-Alcoholic Fatty Liver Disease FLEET, TIFFANY BAYLOR COLLEGE OF MEDICINE TX $44,044
Liver Cancer 2017 NCI 5R01CA198103-02 ER stress and UPR in non-alcoholic steatohepatitis and hepatocellular carcinoma KAUFMAN, RANDAL SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $707,261
Liver Cancer 2017 NCI 5R01CA051497-26 MYC--Transcription and Apoptosis DANG, CHI UNIVERSITY OF PENNSYLVANIA PA $27,000
Liver Cancer 2017 NCI 5R01CA172713-05 PATTERNS OF r AAV VECTOR INSERTION ASSOCIATED WITH LIVER TUMORS IN A MOUSE MODEL FU, HAIYAN RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $303,988
Liver Cancer 2017 NCI 5R01CA194533-03 Endovascular Chemofiltration: Optimizing Removal of Chemotherapeutics and Nanoparticles from the Blood to Reduce Toxicity HETTS, STEVEN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $513,934
Liver Cancer 2017 NIDDK 5R01DK107288-03 S-Adenosylmethionine in Protein Posttranslational Modifications and HCC Treatment LU, SHELLY CEDARS-SINAI MEDICAL CENTER CA $430,504
Liver Cancer 2017 NCI 5R00CA190783-03 Mass Spectrometry Imaging for Clinical Diagnosis and Prognosis of Human Cancers SCHIAVINATO EBERLIN, LIVIA UNIVERSITY OF TEXAS, AUSTIN TX $191,648
Liver Cancer 2017 NCCIH 5R01AT001576-15 Role of SAMe in Pathogenesis and Treatment of Non-Alcholic Fatty Liver Disease LU, SHELLY CEDARS-SINAI MEDICAL CENTER CA $295,647
Liver Cancer 2017 NCI 5R01CA174735-04 The role of MDM2-MTBP axis in cancer metastasis IWAKUMA, TOMOO UNIVERSITY OF KANSAS MEDICAL CENTER KS $313,325
Liver Cancer 2017 NIEHS 5R01ES025909-03 Molecular Basis of Cancer Cell Metabolic Reprogramming WANG, LI UNIVERSITY OF CONNECTICUT STORRS CT $355,500
Liver Cancer 2017 NIBIB 5R01EB018849-04 Ultrasound-Guided Robotic Needle Steering for Ablation of Liver Cancer OKAMURA, ALLISON STANFORD UNIVERSITY CA $360,615
Liver Cancer 2017 NCI 5R01CA197128-03 Molecular mechanisms of focal adhesion kinase in promoting hepatocarcinogenesis QIU, WEI LOYOLA UNIVERSITY CHICAGO IL $346,980
Liver Cancer 2017 NCI 2P01CA087497-16A1 5245 Core C - The Molecular Systems Pathology Core CORDON-CARDO, CARLOS ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $262,699
Liver Cancer 2017 NIDDK 5R01DK097249-05 Med1 in Liver Metabolism, Regeneration and Cancer THIMMAPAYA, BAYAR NORTHWESTERN UNIVERSITY AT CHICAGO IL $336,038
Liver Cancer 2017 NCI 5R21CA202396-02 The role of IL-27 cytokine in hepatocellular carcinoma (HCC) development KOLTSOVA, EKATERINA RESEARCH INST OF FOX CHASE CAN CTR PA $199,013
Liver Cancer 2017 NCI 5R01CA202769-02 Development of cell-free DNA assays for HCC screening and liquid biopsy SU, YING-HSIU BARUCH S. BLUMBERG INSTITUTE PA $472,981
Liver Cancer 2017 NCI 5K08CA194268-04 Novel targeted therapies for isocitrate dehydrogenase mutantcholangiocarcinoma SAHA, SUPRIYA FRED HUTCHINSON CANCER RESEARCH CENTER WA $169,020
Liver Cancer 2017 NCI 5K08CA172288-06 Mechanisms and modifiers of beta-catenin-induced hepatic tumorigenesis EVASON, KIMBERLEY UNIVERSITY OF UTAH UT $150,763
Liver Cancer 2017 NCI 5R01CA195524-02 Early Detection of Hepatocellular Carcinoma BERETTA, LAURA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $611,462
Liver Cancer 2017 NIAAA 5R01AA023146-12 Role of Beta Spectrin and Smad in Alcohol Induced Liver and GI Cell Proliferation MISHRA, LOPA GEORGE WASHINGTON UNIVERSITY DC $285,300
Liver Cancer 2017 NIGMS 5P20GM113226-02 6174 High fat diet induced hepatocyte exosomes-promoted hepatic inflammation and tumorigenesis DENG, ZHONG-BIN UNIVERSITY OF LOUISVILLE KY $189,233
Liver Cancer 2017 NCI 5R01CA203985-02 Mechanism of Met-Induced Hepatocyte Survival ZARNEGAR, REZA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $352,275
Liver Cancer 2017 NCI 5R01CA183764-03 The Cholangiocyte Primary Cilium as a Tumor Suppressor Organelle GRADILONE, SERGIO UNIVERSITY OF MINNESOTA MN $348,844
Liver Cancer 2017 NCI 5R01CA195787-03 A scalable platform for target validation in GEMM models of gastrointestinal malignancies. LOWE, SCOTT SLOAN-KETTERING INST CAN RESEARCH NY $641,206
Liver Cancer 2017 NCI 1K99CA215315-01 Regulation of tumor growth and metabolism by hyperinsulinemia PERRY, RACHEL YALE UNIVERSITY CT $148,502
Liver Cancer 2017 NCI 1R21CA209940-01A1 Integrative genomic framework for dissecting regulatory mechanisms underlying hepatocellular carcinoma POCHET, NATHALIE BRIGHAM AND WOMEN'S HOSPITAL MA $227,331
Liver Cancer 2017 NCI 5R01CA188506-03 Dissection of Pten-regulated signals in hepatopathogenesis FENG, GEN-SHENG UNIVERSITY OF CALIFORNIA SAN DIEGO CA $354,563
Liver Cancer 2017 NCI 5R01CA196692-03 Does Screening for HCC in Cirrhotic Patients Reduce HCC-related Mortality? IOANNOU, GEORGE SEATTLE INST FOR BIOMEDICAL/CLINICAL RES WA $273,336
Liver Cancer 2017 NCI 1R01CA209888-01A1 Therapeutic miRNA Modulation of Hepatocellular Carcinoma Using Ultrasound Guided Drug Delivery WILLMANN, JUERGEN STANFORD UNIVERSITY CA $617,907
Liver Cancer 2017 NCI 5U01CA188387-03 Gut microbiota mediated bile acid alterations in hepatic carcinogenesis JIA, WEI UNIVERSITY OF HAWAII AT MANOA HI $562,180
Liver Cancer 2017 NIAAA 5U01AA022614-04 The Role of IL-17 in Alcoholic Liver Disease and Cancer KISSELEVA, TATIANA UNIVERSITY OF CALIFORNIA SAN DIEGO CA $353,250
Liver Cancer 2017 NCI 5U01CA185188-03 Analysis of Racial Disparities in HCC by Systems Metabolomics RESSOM, HABTOM GEORGETOWN UNIVERSITY DC $255,915
Liver Cancer 2017 NCI 5R01CA160254-06 Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach LUBMAN, DAVID UNIVERSITY OF MICHIGAN MI $360,861
Liver Cancer 2017 NCI 5R01CA206167-02 Hexokinase 2 in liver cancer HAY, NISSIM UNIVERSITY OF ILLINOIS AT CHICAGO IL $442,913
Liver Cancer 2017 NCI 5R44CA165314-04 A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC) LU, XUANYONG IMCARE BIOTECH PA $654,671
Liver Cancer 2017 NCI 1R03CA208311-01A1 Inducible systems for studying liver tumor mainenance in vivo CHEN, XIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $79,250
Liver Cancer 2017 NCI 5R01CA182264-04 Development of Advanced C-arm Cone-Beam CT for the Treatment of Liver Cancer PAN, XIAOCHUAN UNIVERSITY OF CHICAGO IL $436,757
Liver Cancer 2017 NIDDK 5R01DK106395-02 Metabolic imaging of nonalcoholic fatty liver disease MAYER, DIRK UNIVERSITY OF MARYLAND BALTIMORE MD $449,029
Liver Cancer 2017 NCI 1R03CA216153-01 Potential Role of the Novel Angiopoietin-like Protein RIFL/Angptl8 in Hepatocellular Carcinoma SMAS, CYNTHIA UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS OH $76,750
Liver Cancer 2017 NCI 5K08CA193915-03 The Mechanism of Tumor Formation in Beckwith-Wiedemann Syndrome KALISH, JENNIFER CHILDREN'S HOSP OF PHILADELPHIA PA $140,504
Liver Cancer 2017 NIBIB 2R01EB007643-09A1 Design of Noninvasive Therapies Utilizing Nonlinear Focused Ultrasound With Shocks KHOKHLOVA, VERA UNIVERSITY OF WASHINGTON WA $603,112
Liver Cancer 2017 NCI 5P01CA059827-19 5908 Response-driven Treatment of Hepatocellular Carcinoma LAWRENCE, THEODORE UNIVERSITY OF MICHIGAN MI $342,673
Liver Cancer 2017 NCI 5R01CA172302-05 Genetics pathways in intra-hepatic cholangiocarcinoma HEZEL, ARAM UNIVERSITY OF ROCHESTER NY $318,513
Liver Cancer 2017 NCI 5R01CA206465-02 (PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer JUSTICE, AMY YALE UNIVERSITY CT $527,068
Liver Cancer 2017 NCI 5R01CA203565-03 Nutritional Control of Cancer Cell Function by Amino Acids KILBERG, MICHAEL UNIVERSITY OF FLORIDA FL $343,125
Liver Cancer 2017 NCI 5R01CA200007-03 Multiplexed imaging of biliary intra-epithelial neoplasia SEIBEL, ERIC UNIVERSITY OF WASHINGTON WA $569,599
Liver Cancer 2017 NIAAA 1R01AA025204-01A1 NANOG-positive cancer stem cells in liver oncogenesis induced by alcohol and HCV MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $371,250
Liver Cancer 2017 NCI 5R01CA080024-20 Intra and Extra-Chromosomal Probes for Mutagenesis by Carcinogens ESSIGMANN, JOHN MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $339,960
Liver Cancer 2017 NIAAA 1K08AA025112-01A1 Stearoyl-CoA Desaturase in Alcohol-Promoted Liver Tumorigenesis LAI, KEANE UNIVERSITY OF SOUTHERN CALIFORNIA CA $195,588
Liver Cancer 2017 NCI 5F31CA210639-02 Improving Sorafenib; a multi-targeted kinase inhibitor used for the treatment of hepatocellular carcinoma by mechanistically dissecting out its underlying targets and anti-targets YU, JIA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $41,244
Liver Cancer 2017 NCI 5R01CA196967-03 MRI-Guided Irreversible Electroporation Ablation for Liver Tumors ZHANG, ZHUOLI NORTHWESTERN UNIVERSITY AT CHICAGO IL $347,209
Liver Cancer 2017 NCI 5R01CA206180-02 Quantitative Multimodal Image Guidance for Improved Liver Cancer Treatment DUNCAN, JAMES YALE UNIVERSITY CT $644,766
Liver Cancer 2017 NCI 5R01CA201127-02 Simultaneous Thermal and Osmotic Stresses in Tumor Ablation: Imaging and Biology CRESSMAN, ERIK UNIVERSITY OF TX MD ANDERSON CAN CTR TX $373,496
Liver Cancer 2017 NIDDK 5R01DK105198-02 Metabolic Regulation of Liver Growth GOESSLING, WOLFRAM BRIGHAM AND WOMEN'S HOSPITAL MA $547,130
Liver Cancer 2017 NIDDK 2R01DK044533-19A1 Mechanisms of Hepatocyte Transformation by the Hepatitis B Virus X Protein ANDRISANI, OURANIA PURDUE UNIVERSITY IN $343,736
Liver Cancer 2017 NCI 5R21CA201867-02 Neurotensin in Fibrolamellar Liver Cancer RIEHLE, KIMBERLY UNIVERSITY OF WASHINGTON WA $201,623
Liver Cancer 2017 NIAID 1R21AI131328-01A1 AAV2 and hepatocellular carcinoma SRIVASTAVA, ARUN UNIVERSITY OF FLORIDA FL $223,096
Liver Cancer 2017 NCI 5R01CA204145-02 Gut-Related Markers and Hepatocellular Cancer in a Multi-Ethnic Cirrhotic Cohort HUSSAIN, SHEHNAZ CEDARS-SINAI MEDICAL CENTER CA $421,173
Liver Cancer 2017 NCI 5R56CA207929-02 Cellular Pathogenesis of Fibrolamellar Hepatocellular Carcinoma SIMON, SANFORD ROCKEFELLER UNIVERSITY NY $296,625
Liver Cancer 2017 NIDDK 5R01DK107451-02 The role of AEG-1 in NASH and NASH-HCC SARKAR, DEVANAND VIRGINIA COMMONWEALTH UNIVERSITY VA $346,488
Liver Cancer 2017 NCI 5K07CA197179-03 Genetic and Environmental Risk of Liver Disease/Cancer among Mexicans FLORES, YVONNE UNIVERSITY OF CALIFORNIA LOS ANGELES CA $160,920
Liver Cancer 2017 NCI 5P30CA196521-03 7061 Liver Cancer (LC) (Project-003) FRIEDMAN, SCOTT ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $10,690
Liver Cancer 2017 NCI 5R01CA172230-04 TREM-1 and Its Implications to Cancer HORUZSKO, ANATOLIJ AUGUSTA UNIVERSITY GA $315,400
Liver Cancer 2017 RMAP 1K01ES028047-01 Integrating transcriptomic, proteomic and pharmacogenomic data to inform individualized therapy in cancers CHEN, BIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $171,216
Liver Cancer 2017 NCI 2R01CA090764-16 P13K/PTEN/Akt signaling and the genesis of cancer HAY, NISSIM UNIVERSITY OF ILLINOIS AT CHICAGO IL $366,329
Liver Cancer 2017 NCI 5R01CA062130-22 Role of heat shock transcription factor HSF1 in tumoroginesis MIVECHI, NAHID AUGUSTA UNIVERSITY GA $556,510
Liver Cancer 2017 NCI 5P30CA142543-08 6364 Population Science and Cancer Control Scientific Program WILLSON, JAMES UT SOUTHWESTERN MEDICAL CENTER TX $53,118
Liver Cancer 2017 NCI 5R01CA127387-10 Role of the RB tumor suppressor in liver tumorigenesis KNUDSEN, ERIK UNIVERSITY OF ARIZONA AZ $387,406
Liver Cancer 2017 NCI 5U01CA179582-04 The Role of Probiotic Bifidobacteria and Bile Acid Metabolism in Carcinogenesis WAN, YU-JUI UNIVERSITY OF CALIFORNIA AT DAVIS CA $529,373
Liver Cancer 2017 NCI 5R44CA186410-03 Optimization of a clinical stage nanoparticle drug delivery platform BROWN, BOB DICERNA PHARMACEUTICALS, INC. MA $998,609
Liver Cancer 2017 NCI 1F31CA216994-01 Elucidating the role of cell-specific Wnts in hepatocellular carcinoma PREZIOSI, MORGAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $29,637
Liver Cancer 2017 NIDDK 5F32DK109651-02 Mechanisms of differential susceptibility to nonalcoholic fatty liver disease RIORDAN, JESSE PACIFIC NORTHWEST RESEARCH INSTITUTE WA $59,166
Liver Cancer 2017 NIGMS 5P20GM113126-02 5964 Quantifying Biochemical Communication in Hepatocellular Carcinoma STAINS, CLIFF UNIVERSITY OF NEBRASKA LINCOLN NE $172,385
Liver Cancer 2017 RMAP 5UH3TR000884-05 Extracellular non-coding RNA biomarkers of hepatocellular cancer PATEL, TUSHAR MAYO CLINIC JACKSONVILLE FL $921,565
Liver Cancer 2017 NIAAA 1R21AA025841-01 Alcohol enhances colon cancer liver metastasis via cancer-associated fibroblasts SEKI, EKIHIRO CEDARS-SINAI MEDICAL CENTER CA $251,563
Liver Cancer 2017 NCI 5R01CA204373-02 Imaging Liver Cancer Proliferation LEE, ZHENGHONG CASE WESTERN RESERVE UNIVERSITY OH $395,646
Liver Cancer 2017 NIGMS 1R01GM123766-01 Systems Metabolomics for HCC Biomarker Discovery RESSOM, HABTOM GEORGETOWN UNIVERSITY DC $311,000
Liver Cancer 2017 NCI 1R01CA211602-01A1 Large aperture and wideband modular ultrasound arrays for the diagnosis of liver cancer FERRARA, KATHERINE UNIVERSITY OF CALIFORNIA AT DAVIS CA $667,368
Liver Cancer 2017 FIC 5U54CA190165-04 7860 Adminstrative and Coordinating Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $8,454
Liver Cancer 2017 NCI 5U54CA190165-04 7860 Adminstrative and Coordinating Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $113,494
Liver Cancer 2017 FIC 5U54CA190165-04 7861 The Role of HIV Infection in the Etiology and Clinical Manifestations of Hep Carcinoma KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $12,427
Liver Cancer 2017 NCI 5U54CA190165-04 7861 The Role of HIV Infection in the Etiology and Clinical Manifestations of Hep Carcinoma KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $166,836
Liver Cancer 2017 FIC 5U54CA190165-04 7862 Pre Malignant Cirrhosis and Hepatocellular Carcinoma in HIV Infected Ugandans KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $15,443
Liver Cancer 2017 NCI 5U54CA190165-04 7862 Pre Malignant Cirrhosis and Hepatocellular Carcinoma in HIV Infected Ugandans KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $207,321
Liver Cancer 2017 FIC 5U54CA190165-04 7863 Biomarker and Analytical Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $9,348
Liver Cancer 2017 NCI 5U54CA190165-04 7863 Biomarker and Analytical Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $125,498
Liver Cancer 2017 FIC 5U54CA190165-04 7874 Developmental Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $6,314
Liver Cancer 2017 NCI 5U54CA190165-04 7874 Developmental Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $84,765
Liver Cancer 2017 RMAP 5U19CA179512-05 7166 Function of Extracellular Small RNAs in Conditional Mouse Models of Liver Cancer BLELLOCH, ROBERT UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $166,529
Liver Cancer 2017 NCI 5R01CA177686-05 Regulation of molecular thermal ablative resistance in hepatocellular carcinoma WOODRUM, DAVID MAYO CLINIC ROCHESTER MN $329,925
Liver Cancer 2017 RMAP 5UH3TR000914-05 Targeted delivery of microRNA-loaded microvesicle for cancer therapy SCHMITTGEN, THOMAS UNIVERSITY OF FLORIDA FL $768,797
Liver Cancer 2017 NIDDK 5R01DK103735-02 Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B COOPER, STEWART CALIFORNIA PACIFIC MED CTR RES INSTITUTE CA $723,189
Liver Cancer 2017 NCI 5R44CA203276-02 Development and testing of MRI-mediated radiofrequency ablation system and probes NEVO, EREZ ROBIN MEDICAL, INC. MD $749,102
Liver Cancer 2017 NCI 1R41CA213678-01A1 Development, Characterization & Commercialization of a Viably Frozen, Patient-Inclusive Hepatocellular Carcinoma Tumor Bank BRIGGS, MICHAEL WOODLAND PHARMACEUTICALS, LLC MA $299,999
Liver Cancer 2017 NCI 2R42CA183376-02 Noninvasive Contrast Enhanced Early Detection of Melanoma Liver Metastasis YANG, JENNY INLIGHTA BIOSCIENCES, LLC GA $602,227
Liver Cancer 2017 NIDDK 1R01DK110024-01A1 Epigenetic Mechanisms Underlying Hepatitis C-Induced Hepatocarcinogenesis ROBERTSON, KEITH MAYO CLINIC ROCHESTER MN $620,487
Liver Cancer 2017 NCI 5R01CA135069-08 Glycans in Hepatocellular Carcinoma GOLDMAN, RADOSLAV GEORGETOWN UNIVERSITY DC $403,713
Liver Cancer 2017 NCI 5R42CA168123-03 In-Situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma GHANDEHARI, HAMID THERATARGET UT $694,475
Liver Cancer 2017 NCI 5R01CA197081-02 Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation AHMED, MUNEEB BETH ISRAEL DEACONESS MEDICAL CENTER MA $474,276
Liver Cancer 2017 NIDDK 5K01DK106346-03 Altered endosomal protein sorting in the pathogenesis of hepatocellular carcinoma SINGLA, AMIKA UT SOUTHWESTERN MEDICAL CENTER TX $124,040
Liver Cancer 2017 NCI 5DP5OD021391-03 Image-Based Phenotyping of Hepatocellular Carcinoma Cell Survival Under Ischemic Stress: Toward Metabolic Imaging of Cancer Dormancy Using Hyperpolarized Carbon-13 Technology GADE, TERENCE UNIVERSITY OF PENNSYLVANIA PA $392,293
Liver Cancer 2017 NIDCR 5DP5OD021391-03 Image-Based Phenotyping of Hepatocellular Carcinoma Cell Survival Under Ischemic Stress: Toward Metabolic Imaging of Cancer Dormancy Using Hyperpolarized Carbon-13 Technology GADE, TERENCE UNIVERSITY OF PENNSYLVANIA PA $1
Liver Cancer 2017 NIBIB 5R01EB022075-02 Imaging and Dosimetry of Yttrium-90 for Personalized Cancer Treatment DEWARAJA, YUNI UNIVERSITY OF MICHIGAN MI $459,820
Liver Cancer 2017 NCI 5P30CA014089-42 8293 Gastrointestinal Cancers Research Program (Project-006) KAHN, MICHAEL UNIVERSITY OF SOUTHERN CALIFORNIA CA $61,950
Liver Cancer 2017 NCI 5P01CA203628-02 7232 Project 3: Targeting SK2/S1P Signaling for the Regulation of c-Myc and Tumor Suppression BRITTEN, CAROLYN MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $238,134
Liver Cancer 2017 NCI 1R01CA219144-01 Interplay between Dietary Fiber and Gut Microbiota in Hepatocellular Carcinoma KUMAR, MATAM PENNSYLVANIA STATE UNIVERSITY-UNIV PARK PA $293,909
Liver Cancer 2017 NCI 1R01CA218442-01 Creation of in vivo active chemical probes for CAMKK2 to treat cancer DREWRY, DAVID UNIV OF NORTH CAROLINA CHAPEL HILL NC $691,617
Liver Cancer 2017 NCI 1R01CA218486-01 Statin Intervention to Slow the Time to Hepatocellular Carcinoma Recurrence in Cirrhotics Awaiting Liver Transplantation HUSSAIN, SHEHNAZ CEDARS-SINAI MEDICAL CENTER CA $697,142
Liver Cancer 2017 NCI 5P30CA015704-42 5445 Research Program: Gastrointestinal Cancer GRADY, WILLIAM FRED HUTCHINSON CANCER RESEARCH CENTER WA $118,761
Liver Cancer 2017 NCI 1R03CA208215-01A1 SWI/SNF complex in mouse HCC development CHEN, XIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $79,250
Liver Cancer 2017 NCI 1R01CA208735-01A1 (PQ7)Multi-scale Analysis of Tumor Microenvironment Heterogeneity FELSHER, DEAN STANFORD UNIVERSITY CA $729,393
Liver Cancer 2017 NCI 3R01CA193244-07S1 Role of microR-122 in Hepatocarcinogenesis using Conditional Knockout Mice GHOSHAL, KALPANA OHIO STATE UNIVERSITY OH $40,177
Liver Cancer 2017 NIDDK 1R01DK111547-01A1 Regional Cholangiocyte Stress Responses in Biliary Disease PACK, MICHAEL UNIVERSITY OF PENNSYLVANIA PA $402,500
Liver Cancer 2017 NCI 1R01CA212008-01A1 Harms of Hepatocellular Carcinoma Screening in Patients with Cirrhosis SINGAL, AMIT UT SOUTHWESTERN MEDICAL CENTER TX $690,111
Liver Cancer 2017 NIAAA 5F32AA025271-02 The role of mechanical signaling in alcoholic liver disease and hepatocellular carcinoma WRIGHTON, PAUL BRIGHAM AND WOMEN'S HOSPITAL MA $57,066
Liver Cancer 2017 NCI 1R01CA215520-01A1 CONTRAST-ENHANCED ULTRASOUND EVALUATION OF FOCAL LIVER LESIONS IN PATIENTS WITH CIRRHOSIS OR OTHER RISK FACTORS FOR DEVELOPING HCC LYSHCHIK, ANDREJ THOMAS JEFFERSON UNIVERSITY PA $727,335
Liver Cancer 2017 NCATS 1UH2TR002087-01 Utilization of Phenotypic Precision Medicine to Identify Optimal Drug Combinations for the Treatment of Hepatocellular Carcinoma ZARRINPAR, ALI UNIVERSITY OF FLORIDA FL $286,725
Liver Cancer 2017 NIBIB 1R21EB023605-01A1 Exploring combined hyperpolarized 13C MRI with liver-specific gadolinium contrast agents for improved metabolic assessment of liver tumors OHLIGER, MICHAEL UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $237,750
Liver Cancer 2017 NCI 3R01CA172713-04S1 PATTERNS OF r AAV VECTOR INSERTION ASSOCIATED WITH LIVER TUMORS IN A MOUSE MODEL MCCARTY, DOUGLAS RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $25,683
Liver Cancer 2017 NCI 1R01CA215702-01A1 Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma CORBIN, IAN UT SOUTHWESTERN MEDICAL CENTER TX $370,575
Liver Cancer 2017 NIDDK 5F32DK111151-02 A Balancing Act: Role of HNF4α/β-catenin in Hepatobiliary Development and Cholangiocarcinoma Formation WALESKY, CHAD BRIGHAM AND WOMEN'S HOSPITAL MA $59,166
Liver Cancer 2017 NCI 3U01CA185188-03S1 Analysis of Racial Disparities in HCC by Systems Metabolomics RESSOM, HABTOM GEORGETOWN UNIVERSITY DC $73,651
Liver Cancer 2017 NIDDK 3F32DK109651-01A1S1 Mechanisms of differential susceptibility to nonalcoholic fatty liver disease RIORDAN, JESSE PACIFIC NORTHWEST RESEARCH INSTITUTE WA $553
Liver Cancer 2017 NCI 4R00CA191152-03 Development of mosaic mouse models of HCC for genetic interspecies inference FONT-BURGADA, JOAN RESEARCH INST OF FOX CHASE CAN CTR PA $249,000
Liver Cancer 2017 NCI 1F31CA220997-01 Probing the role of a highly expressed lncRNA in hepatocellular carcinoma YU, ALLEN STATE UNIVERSITY NEW YORK STONY BROOK NY $35,584
Liver Cancer 2017 NCI 1R13CA216895-01A1 Hepatobiliary Cancers: Pathobiology and Translational Advances SIRICA, ALPHONSE VIRGINIA COMMONWEALTH UNIVERSITY VA $2,250
Liver Cancer 2017 NCI 1R01CA208396-01A1 Combination of ceramide and immunotherapy in treatment of hepatocellular cancer STAVELEY-O'CARROLL, KEVIN UNIVERSITY OF MISSOURI-COLUMBIA MO $531,242
Liver Cancer 2017 FIC 1U54CA221205-01 6395 Epigenetic Biomarkers of HIV-Associated Hepatocellular Carcinoma in Nigeria ROBERTS, LEWIS NORTHWESTERN UNIVERSITY AT CHICAGO IL $29,604
Liver Cancer 2017 NCI 1U54CA221205-01 6395 Epigenetic Biomarkers of HIV-Associated Hepatocellular Carcinoma in Nigeria ROBERTS, LEWIS NORTHWESTERN UNIVERSITY AT CHICAGO IL $217,703
Liver Cancer 2017 NCI 2R44CA183265-02A1 FrostBite - A Unique Catheter for Endoscopic Cryoablation BAUST, J CELL PRESERVATION SERVICES, INC. NY $1,008,442
Liver Cancer 2017 NCI 1F99CA222741-01 Metabolic rewiring regulates cancer growth and tumor-associated immune responses ZHAO, STEVEN UNIVERSITY OF PENNSYLVANIA PA $45,544
Liver Cancer 2017 NCI 3R01CA184456-02S2 VDAC Regulation of Warburg Metabolism in Hepatocarcinoma MALDONADO, EDUARDO MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $25,857
Liver Cancer 2017 NCI 7R01CA121275-09 Tumor suppressor roles of E2F7 & E2F8 in hepatocellular carcinoma LEONE, GUSTAVO MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $271,221
Liver Cancer 2017 NCI 3R01CA201127-02S1 Simultaneous Thermal and Osmotic Stresses in Tumor Ablation: Imaging and Biology CRESSMAN, ERIK UNIVERSITY OF TX MD ANDERSON CAN CTR TX $203,733
Liver Cancer 2017 NCI 3R01CA186566-03S1 Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC) HASSAN, MANAL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $113,799
Liver Cancer 2017 NIAAA 3F32AA025271-01S1 The role of mechanical signaling in alcoholic liver disease and hepatocellular carcinoma WRIGHTON, PAUL BRIGHAM AND WOMEN'S HOSPITAL MA $1,426
Liver Cancer 2017 NIDDK 3F32DK111151-01A1S1 A Balancing Act: Role of HNF4α/β-catenin in Hepatobiliary Development and Cholangiocarcinoma Formation WALESKY, CHAD BRIGHAM AND WOMEN'S HOSPITAL MA $727
Liver Cancer 2017 NIEHS 2P42ES010337-16 5946 Core-005: Training Core MELLON, PAMELA UNIVERSITY OF CALIFORNIA SAN DIEGO CA $121,274
Liver Cancer 2017 NCI 261201200042I-2-26100007-1 CONTRACTOR: MAYO CLINIC; DUNNS: 006471700; PILOT STUDY OF EGFR INHIBITION WITH ERLOTINIB IN CIRRHOSIS TO INHIBIT FIRBROGENESIS AND PREVENT HEPATOCELLULAR CARCINOMA HHSN261201200042I; TASK ORDER HHSN26 LIMBURG, PAUL MAYO CLINIC ROCHESTER MN $96,186
Liver Cancer 2017 NIEHS 1R56ES027632-01A1 The roles of BER and TLS in limiting aflatoxin-induced carcinogenesis LLOYD, R. OREGON HEALTH & SCIENCE UNIVERSITY OR $308,000
Liver Cancer 2017 NCI 7R01CA051497-27 Myc - Transcription and Apoptosis DANG, CHI WISTAR INSTITUTE PA $350,375
Liver Cancer 2017 NCI 1ZIACP005782-23 Epidemiology of Oncogenic Viruses O'BRIEN, THOMAS NIH $157,625
Liver Cancer 2017 NCI 1ZIACP010127-22 Etiologic Studies of Diet and Cancer FREEDMAN, NEAL NIH $278,690
Liver Cancer 2017 NCI 1ZIACP010128-22 Therapeutic and Diagnostic Factors as Related to Cancer Risk TRABERT, BRITTON NIH $516,496
Liver Cancer 2017 NCI 1ZIACP010158-17 Studies of Rare Cancers MCGLYNN, KATHERINE NIH $434,550
Liver Cancer 2017 NCI 1ZIACP010184-15 Consultation and Collaboration GRAUBARD, BARRY NIH $910,442
Liver Cancer 2017 NICHD 1ZIAHD000912-38 Molecular Genetics Of Heritable Human Disorders CHOU, JANICE NIH $1,296,425
Liver Cancer 2017 NICHD 1ZIAHD008804-11 The Role of Carboxypeptidase E in Cancer LOH, YOKE PENG NIH $428,245
Liver Cancer 2017 NCATS 1ZIATR000118-03 NPC/MIPE Toxicity Screen of IDH1 Inhibitors against Cholangiocarcinoma Cell Lines HALL, MATTHEW NIH $135,676
Liver Cancer 2017 NCATS 1ZIATR000294-01 PRKACA for Fibrolamellar hepatocellular carcinoma SIMEONOV, ANTON NIH $44,666
Liver Cancer 2017 NIBIB 3R21EB022291-02S1 Transarterial Immunomodulatory Embolization: A novel approach to cancer therapy AMEER, GUILLERMO NORTHWESTERN UNIVERSITY IL $52,282
Liver Cancer 2017 NCI 1ZIABC005598-28 Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells GOTTESMAN, MICHAEL NIH $818,215
Liver Cancer 2017 NCI 1ZIABC005708-26 Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers GONZALEZ, FRANK NIH $1,031,958
Liver Cancer 2017 NCI 1ZIABC005793-23 Mechanism of viral hepatitis-mediated hepatocarcinogenesis WANG, XIN NIH $126,690
Liver Cancer 2017 NCI 1ZIABC010297-20 Identification of Genetic Factors Associated with Infectious Diseases WINKLER, CHERYL NIH $435,778
Liver Cancer 2017 NCI 1ZIABC010313-19 Molecular signatures for liver cancer diagnosis and treatment stratification WANG, XIN NIH $1,013,528
Liver Cancer 2017 NCI 1ZIABC010793-11 Role of inflammation, innate resistance, and immunity in carcinogenesis TRINCHIERI, GIORGIO NIH $1,170,282
Liver Cancer 2017 NCI 1ZIABC010876-10 The role of cancer stem cells in liver cancer heterogeneity and subtypes WANG, XIN NIH $1,013,528
Liver Cancer 2017 NCI 1ZIABC010877-10 The identification of human hepatocellular carcinoma metastasis genes WANG, XIN NIH $380,072
Liver Cancer 2017 NCI 1ZIABC010891-10 Development of new antibody-based cancer therapies HO, MITCHELL NIH $1,311,816
Liver Cancer 2017 NCI 1ZIABC011124-10 Oncogenic Met Signaling in Urologic Malignancies BOTTARO, DONALD NIH $496,098
Liver Cancer 2017 NCI 1ZIABC011343-08 Clinical protocols for the treatment of gastrointestinal cancer GRETEN, TIM NIH $215,076
Liver Cancer 2017 NCI 1ZIABC011744-01 Kinase complexes in human diseases ZHANG, PING NIH $1,287,210
Liver Cancer 2017 NCI 1ZICBC011040-10 Molecular Profiling of Clinical Specimens EDELMAN, DANIEL NIH $3,225,664
Liver Cancer 2017 NCI 1ZIDBC011540-04 Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core HASSAN, RAFFIT NIH $1,890,317
Liver Cancer 2017 NCI 3P30CA142543-08S1 6364 Population Science and Cancer Control Scientific Program WILLSON, JAMES UT SOUTHWESTERN MEDICAL CENTER TX $3,749
Liver Cancer 2017 NIAID 1ZIAAI000999-11 Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases FARCI, PATRIZIA NIH $2,049,409
Liver Cancer 2017 NCI 261201200035I-0-26100013-1 OT::IGF::OT A phase I single-arm, multicenter pilot study aimed at validating y-OHPdG as a biomarker and testing the effects of Polyphenon E on its levels in patients with cirrhosis KHAN, SEEMA NORTHWESTERN UNIVERSITY AT CHICAGO IL $450,103


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer